Indications
Therapeutic Asset Ratings
3,272 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Magrolimab
Breast Cancer
National Cancer Institute (NCI)
P1
D
(30)
Magrolimab
Castration-Resistant Prostate Carcinoma
National Cancer Institute (NCI)
P1
D
(30)
Magrolimab
Prostate Cancer
National Cancer Institute (NCI)
P1
D
(30)
Vismodegib
Endometrial Carcinoma
National Cancer Institute (NCI)
P2
D
(26)
Vismodegib
Head And Neck Carcinoma
National Cancer Institute (NCI)
P2
D
(26)
Selinexor
Glioblastoma
National Cancer Institute (NCI)
P2
D
(21)
cd22 car-transduced t cells
B-Cell Chronic Lymphocytic Leukemia
National Cancer Institute (NCI)
P1
D
(21)
Olanzapine
Glioblastoma
National Cancer Institute (NCI)
P1
D
(21)
Olanzapine
Gliosarcoma
National Cancer Institute (NCI)
P1
D
(21)
Selinexor
IDH-Wildtype Glioblastoma
National Cancer Institute (NCI)
P1/2
D
(21)
Sotorasib
Breast Cancer
National Cancer Institute (NCI)
P2
D
(20)
Sotorasib
Her2-Receptor Negative Breast Cancer
National Cancer Institute (NCI)
P2
D
(20)
Sotorasib
Ovarian Carcinoma
National Cancer Institute (NCI)
P2
D
(20)
Autologous Hucd19 Car T Cells
Lymphoblastic Lymphoma
National Cancer Institute (NCI)
P1/2
D
(20)
Sotorasib
Lung Cancer
National Cancer Institute (NCI)
P2
D
(18)
Vismodegib
Colorectal Carcinoma
National Cancer Institute (NCI)
P2
D
(17)
Vismodegib
Rectal Carcinoma
National Cancer Institute (NCI)
P2
D
(17)
Selinexor
Gliosarcoma
National Cancer Institute (NCI)
P1
D
(17)
Sotorasib
Non-Small Cell Lung Carcinoma
National Cancer Institute (NCI)
P3
D
(15)
Sotorasib
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)
P2
D
(15)
Sotorasib
Endometrial Carcinoma
National Cancer Institute (NCI)
P2
D
(15)
Sotorasib
Fallopian Tube Carcinoma
National Cancer Institute (NCI)
P2
D
(15)
Sotorasib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)
P2
D
(15)
Vismodegib
Lymphoma
National Cancer Institute (NCI)
P2
D
(15)
Vismodegib
Cervical Carcinoma
National Cancer Institute (NCI)
P2
D
(15)
Showing 3226 to 3250 of 3,272 assets
Previous
Page 130 of 131
Next